Lantern Pharma Inc. Common Stock (LTRN)
Stock · NASDAQ · Health Care
$2.07as of 8/28/2026
Price chart
Open in TradingViewActive signals
High Beta61.4%
Resistance level
$2.64
Industry
Biotechnology: Pharmaceutical Preparations
About LTRN
Lantern Pharma Inc. focuses on the discovery and development of oncology drug in India. Its product pipeline comprises LP-300, which is in phase 2 clinical trial in combination therapy for never-smokers with non-small cell lung cancer adenocarcinoma; LP-184, which is in phase 1a clinical trial for the treatment of advanced or metastatic solid tumors, or unresectable or recurrent GBM, solid tumor, such as pancreatic,…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 16
- Website
- www.lanternpharma.com/
Fundamentals
- 1-day range
- $2.07$2.19
- Market cap
- $33.30M
- P/E (trailing)
- —
- P/E (forward)
- -1.02
- EPS (trailing)
- $-1.45
- Dividend yield
- —
- Beta
- 2.26
- Avg. volume
- 151.3K
52-week range
$1.11$4.7
Next earnings: November 11, 2026 · EPS estimate $-0.38confirmed
Forecasts
2 analyst ratings
Buy 86%
Hold 14%
Sell 0%
1-year price forecast
High
$25
+1107.7%
Median
$17.5
+745.4%
Low
$10
+383.1%
Lantern Pharma Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- LTRNLantern Pharma Inc. Common Stock$2.08▼ 3.70%Market cap $33.30MP/E —$1.11$4.7
- IXHLIncannex Healthcare Inc. Common Stock$3.61▼ 2.17%Market cap $35.06MP/E —$2.49$20.64
- ENLVEnlivex Ltd. Ordinary Shares$1.35▼ 8.47%Market cap $36.53MP/E 0.02$1.35$27.15
- APLMApollomics Inc. Class A Ordinary Shares$26.6▲ 1.14%Market cap $37.33MP/E —$3.66$42.12
- BCTXBriaCell Therapeutics Corp. Common Shares$3.73▲ 0.54%Market cap $29.23MP/E —$3.68$20.4
- RMTIRockwell Medical Inc. Common Stock$8.22▲ 6.06%Market cap $28.54MP/E —$4.89$21
- NIKINiki BioSolutions Inc. Common Stock$6.9▼ 8.49%Market cap $28.45MP/E —$7.01$12.24
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| LTRN Lantern Pharma Inc. Common Stock | $33.30M | — | $2.08 | ▼ 3.70% | $1.11$4.7 |
| IXHL Incannex Healthcare Inc. Common Stock | $35.06M | — | $3.61 | ▼ 2.17% | $2.49$20.64 |
| ENLV Enlivex Ltd. Ordinary Shares | $36.53M | 0.02 | $1.35 | ▼ 8.47% | $1.35$27.15 |
| APLM Apollomics Inc. Class A Ordinary Shares | $37.33M | — | $26.6 | ▲ 1.14% | $3.66$42.12 |
| BCTX BriaCell Therapeutics Corp. Common Shares | $29.23M | — | $3.73 | ▲ 0.54% | $3.68$20.4 |
| RMTI Rockwell Medical Inc. Common Stock | $28.54M | — | $8.22 | ▲ 6.06% | $4.89$21 |
| NIKI Niki BioSolutions Inc. Common Stock | $28.45M | — | $6.9 | ▼ 8.49% | $7.01$12.24 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Lantern Pharma (LTRN) Q2 2026 Earnings Call TranscriptYahoo · 8/21/2026
- Lantern Pharma Inc (LTRN) (Q2 2026) Earnings Call Highlights: AI-Driven Pipeline Advances Amid ...Yahoo · 8/20/2026
- Lantern Pharma Inc. 2026 Q2 - Results - Earnings Call PresentationSeekingAlpha · 8/17/2026
- Lantern Pharma Inc. Q2 2026 Earnings Call SummaryYahoo · 8/14/2026
- Lantern Pharma Inc. (LTRN) Q2 2026 Earnings Call TranscriptSeekingAlpha · 8/14/2026
- Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business UpdateYahoo · 8/14/2026
- Lantern Pharma Q2 EPS $(0.57) Misses $(0.38) EstimateBenzinga · 8/14/2026
- Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ETYahoo · 8/7/2026
Insider Activity
Insider Actions →Acquired
97.1K
Disposed
0
- Lee Troy Schalop · May 12, 2026 · Buy48.5K @ $2.06
- D. Jeffrey Keyser · May 12, 2026 · Buy48.5K @ $2.06
Institutional Ownership
March 31, 2026
- Total shares held
- 2.02M
- Total value held
- $2.76M
- Institutional holders
- 29
Top holders this quarter
- Unknown864.4K
- Unknown332.1K
- Unknown250.0K
- Unknown116.0K
- Unknown111.6K
- Unknown50.0K
- Unknown50.0K
- Unknown45.3K
- Unknown38.1K
- Unknown26.4K
See the full, filterable feed with live charts on the MarketWall dashboard.